Xie H Erin 4

What Happened Erin Xie, a portfolio manager at BlackRock Health Sciences Term Trust (BMEZ), reported multiple derivative transactions on 2026-01-30. She converted/exercised 25,676.274 derivative units that were disposed back to the issuer for $15.21 per unit, generating $390,536 in cash. At the same time she was recorded as acquiring a grant/award of 17,560.493 phantom shares valued at $15.21 each (total value $267,095). The filing also lists three additional derivative exercises/conversions (8,915.347; 8,861.551; and 7,899.377 units) reported without separate cash amounts.

Key Details

• Transaction date: January 30, 2026; Form 4 filed February 3, 2026 (timely filing).
• Cash disposition: 25,676.274 shares sold to issuer at $15.21 — proceeds reported $390,536.
• Award received: 17,560.493 phantom shares valued at $15.21 — reported value $267,095.
• Other derivative entries: exercises/conversions of 8,915.347; 8,861.551; and 7,899.377 units reported (no cash price listed).
• Footnotes: These are phantom-share awards (F1) that are cash-settled on vesting; prior grants from Jan 31 of 2023–2025 vest in equal installments over three years (F2–F5).
• Shares owned after the transactions are not specified in the filing.

Context Phantom shares are a form of deferred cash compensation tied to the company’s common-stock value; they do not represent actual stock ownership and are payable in cash on vesting. In this case the conversion and immediate disposition to the issuer indicate a cash settlement of vested phantom units (similar to exercising a cash-settled derivative), while the A-coded line reflects receipt of additional phantom-share awards. These entries are routine compensation/settlement events and should not be read as an explicit investment endorsement or rejection by the insider.